Re: is this the cure

[Guest guest]

This is a terrible hoax.

IF it works one jab is all you need.  Price $40,000!

Too bad there is nothing at all to this, because RA has nothing at all to do

with a 'malfunctioning' immune system.  AND if it were, could it be fixed with

just one 'jab'?  NO!

So although I am glad they are looking in to this, it is too bad they have the

wrong idea and are trying to solve it through genetic engineering.  I would be

LAST in line for this treatment.

Thanks for posting this,

From: Eva Holloway <holloway-eva@...>

Subject: rheumatic is this the cure

rheumatic

Date: Thursday, August 14, 2008, 7:50 AM

I forwarded this but it did not work the first time, hope everyone

gets this. It is from another arthritis group (PsA)

Eva

This is taken from the guardian Newspaper in the UK

URL: http://tinyurl. com/5drtsx

One injection 'vaccine' cure for arthritis within five years

A single injection that could cure rheumatoid arthritis is being developed by

British scientists.

By , Medical Editor

Last Updated: 6:37PM BST 13 Aug 2008

Rheumatoid arthritis is difficult to treat because it is caused by a

malfunctioning immune system Photo: PAUL GROVER The treatment works like a

vaccine and could be available within five years. Cells would be taken from the

body, altered, and injected back into the affected joint.

A team at Newcastle University will now test the vaccine on volunteers with the

disease.

Scientists in the field are extremely excited about the development.

There are 350,000 people in the UK with rheumatoid arthritis, which is a

condition where the body's immune system attacks the joints, unlike

oestoarthritis which is more like wear and tear of the joints.

Rheumatoid arthritis is difficult to treat because it is caused by a

malfunctioning immune system, causing inflammation in the wrong places.

Prof Alan Silman, medical director of the charity Arthritis Research

Campaign, which funded the research, said: " This is an important potential cure.

It is possible one injection could switch off the abnormal immune response.

" If it works it could reverse the disease and stop further episodes. "

The Newcastle team will test the effectiveness of the new vaccine in eight

volunteers with rheumatoid arthritis from the Freeman Hospital as part of a

pilot study, which could then lead to larger trials.

The vaccine works by reprogramming the body's own immune cells.

Using chemicals, steroids and Vitamin D, the team has devised a way to

manipulate a patient's white blood cells so they surpress, rather than

activate, the immune system.

It is thought the cells will then act as a brake on the over-reacting immune

system and stop it attacking its own joints.

Although a similar technique has been used in cancer research, this is the first

time it has been adapted to rheumatoid arthritis.

Isaacs, Professor of Clinical Rheumatology at Newcastle University's

Musculoskeletal Research Group, who is leading the team, said that although the

work was in a very early, experimental stage it was " hugely exciting " .

" Based on previous laboratory research we would expect that this will

specifically suppress or down regulate the auto-immune response, " he said.

Samples will be taken two weeks after the injection to establish whether it has

induced the expected response.

The team also hope to find out if the vaccine is effective only in the

joints it is injected into, or whether the new cells spread throughout the body.

Prof Silman said the treatment may prove expensive as each patient would have to

have their own cells taken and manipulated rather than a drug which can be made

in bulk and prescribed to all people with a condition.

He said it would be unlikely that the vaccine could be offered in normal local

hospitals because of the expertise necessary to manipulate the cells in the

laboratory.

It raises fears the vaccine would have to go through the National Institute for

health and Clinical Excellence cost effectiveness tests.

But if the vaccine did work with a one off injection and completely stop the

disease it is likely to offer such a huge benefit to the patient that even a

relatively large price may be deemed acceptable. Prof Silman said he expected

the jab to cost less than £25,000.

The research is being funded by medical research charity the Arthritis

Research Campaign, which is providing £216,000 over 18 months.

[Guest guest]

Hi, I agree with Merchant.  R/A is not caused by a malfunctioning immune

system.  It is caused by mico-mini bacteria.  The immune system is doing the job

it is supposed to be doing by attacking these microbes in the joints.  This is

what causes the inflammation, and joint pain.  That is why antibiotics (although

slow and one antibiotic does not fit all,) is what fights off the disease

causing CWD micoplasmas. Only by getting to the cause of the disease can you

cure it.  Not, no  and never by reprogramming the immune system response. 

Without the immune system response we would be open to a whole other host of

diseases.  That is what steroids does and that hasn't worked.  So, why would

they think that by shutting down the immune response, it would get rid of the

R/A.  It may (like steroidal injections make the pain ease up temporarily,

but once the medication is gone, the pain and crippling is back.)  Dolores  

From: Eva Holloway <holloway-eva@ sbcglobal. net>

Subject: rheumatic is this the cure

rheumatic@grou ps.com

Date: Thursday, August 14, 2008, 7:50 AM

I forwarded this but it did not work the first time, hope everyone gets this. It

is from another arthritis group (PsA)

Eva

This is taken from the guardian Newspaper in the UK

URL: http://tinyurl. com/5drtsx

One injection 'vaccine' cure for arthritis within five years

A single injection that could cure rheumatoid arthritis is being developed by

British scientists.

By , Medical Editor

Last Updated: 6:37PM BST 13 Aug 2008

Rheumatoid arthritis is difficult to treat because it is caused by a

malfunctioning immune system Photo: PAUL GROVER The treatment works like a

vaccine and could be available within five years. Cells would be taken from the

body, altered, and injected back into the affected joint.

A team at Newcastle University will now test the vaccine on volunteers with the

disease.

Scientists in the field are extremely excited about the development.

There are 350,000 people in the UK with rheumatoid arthritis, which is a

condition where the body's immune system attacks the joints, unlike

oestoarthritis which is more like wear and tear of the joints.

Rheumatoid arthritis is difficult to treat because it is caused by a

malfunctioning immune system, causing inflammation in the wrong places.

Prof Alan Silman, medical director of the charity Arthritis Research

Campaign, which funded the research, said: " This is an important potential cure.

It is possible one injection could switch off the abnormal immune response.

" If it works it could reverse the disease and stop further episodes. "

The Newcastle team will test the effectiveness of the new vaccine in eight

volunteers with rheumatoid arthritis from the Freeman Hospital as part of a

pilot study, which could then lead to larger trials.

The vaccine works by reprogramming the body's own immune cells.

Using chemicals, steroids and Vitamin D, the team has devised a way to

manipulate a patient's white blood cells so they surpress, rather than

activate, the immune system.

It is thought the cells will then act as a brake on the over-reacting immune

system and stop it attacking its own joints.

Although a similar technique has been used in cancer research, this is the first

time it has been adapted to rheumatoid arthritis.

Isaacs, Professor of Clinical Rheumatology at Newcastle University's

Musculoskeletal Research Group, who is leading the team, said that although the

work was in a very early, experimental stage it was " hugely exciting " .

" Based on previous laboratory research we would expect that this will

specifically suppress or down regulate the auto-immune response, " he said.

Samples will be taken two weeks after the injection to establish whether it has

induced the expected response.

The team also hope to find out if the vaccine is effective only in the

joints it is injected into, or whether the new cells spread throughout the body.

Prof Silman said the treatment may prove expensive as each patient would have to

have their own cells taken and manipulated rather than a drug which can be made

in bulk and prescribed to all people with a condition.

He said it would be unlikely that the vaccine could be offered in normal local

hospitals because of the expertise necessary to manipulate the cells in the

laboratory.

It raises fears the vaccine would have to go through the National Institute for

health and Clinical Excellence cost effectiveness tests.

But if the vaccine did work with a one off injection and completely stop the

disease it is likely to offer such a huge benefit to the patient that even a

relatively large price may be deemed acceptable. Prof Silman said he expected

the jab to cost less than £25,000.

The research is being funded by medical research charity the Arthritis

Research Campaign, which is providing £216,000 over 18 months.